Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones). [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of CnU Capsule 750 mg for cholesterol gallstones is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholelithiasis

Drugs mentioned

• CnU Capsule 750 mg (CnU)

Snippet

Sponsor: Myungmoon Pharma. Co. Ltd. | Conditions: Cholesterol Cholelithiasis | Phase 4 | Status: RECRUITING